Hospira Epirubicin Hydrochloride Injection 10 mg/5 mL single dose vial

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

epirubicin hydrochloride, Quantity: 2 mg/mL

Commercializzato da:

Hospira Australia Pty Ltd

INN (Nome Internazionale):

epirubicin hydrochloride

Forma farmaceutica:

Injection, solution

Composizione:

Excipient Ingredients: sodium chloride; water for injections

Via di somministrazione:

Intravenous Infusion

Confezione:

5 vials per pack

Classe:

Medicine Listed (Export Only)

Tipo di ricetta:

(S1) This Schedule is intentionally blank

Indicazioni terapeutiche:

1. Relief of subjective and objective symptoms in the following diseases: Acute leukaemia, malignant lymphoma, breast cancer, ovarian cancer, stomach cancer, liver cancer, urothelial cancer (bladder cancer, renal pelvic/ureteral cancer) 2. Treatment of the following malignant cancer in conjunction with other anti-malignant cancer drugs: Breast cancer (pre- and post-operative chemotherapy in operable cases)

Dettagli prodotto:

Visual Identification: Epirubicin Hydrochloride Injection is a clear red solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2013-05-08